Cite
Evaluation of three oral dosages of ondansetron in the prevention of nausea and emesis associated with cyclophosphamide-doxorubicin chemotherapy.
MLA
Fraschini, G., et al. “Evaluation of Three Oral Dosages of Ondansetron in the Prevention of Nausea and Emesis Associated with Cyclophosphamide-Doxorubicin Chemotherapy.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 9, no. 7, July 1991, pp. 1268–74. EBSCOhost, https://doi.org/10.1200/JCO.1991.9.7.1268.
APA
Fraschini, G., Ciociola, A., Esparza, L., Templeton, D., Holmes, F. A., Walters, R. S., & Hortobagyi, G. N. (1991). Evaluation of three oral dosages of ondansetron in the prevention of nausea and emesis associated with cyclophosphamide-doxorubicin chemotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 9(7), 1268–1274. https://doi.org/10.1200/JCO.1991.9.7.1268
Chicago
Fraschini, G, A Ciociola, L Esparza, D Templeton, F A Holmes, R S Walters, and G N Hortobagyi. 1991. “Evaluation of Three Oral Dosages of Ondansetron in the Prevention of Nausea and Emesis Associated with Cyclophosphamide-Doxorubicin Chemotherapy.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 9 (7): 1268–74. doi:10.1200/JCO.1991.9.7.1268.